Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High dose Vitamin C in resectable or metastatic solid tumors
NCT03146962Phase 2Completed
- Sponsor
- Weill Cornell Medicine
- Start
- Mar 2017
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of ascorbic acid in colorectal cancer (CRC), pancreatic cancer (PC) and lung cancer, sponsored by Weill Cornell Medicine. Started Mar 2017; status: completed.
02
Drugs
ascorbic acid
03
Conditions
colorectal cancer (CRC)pancreatic cancer (PC)lung cancer
Beyond the preview
Go deeper on NCT03146962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03146962.